p53 modulation of DNA topoisomerase IIalpha gene expression.
Joshi
A A
AA
Department of Pharmacology, University of Tennessee, Memphis 38163, USA.
Wang
Q
Q
Suttle
D P
DP
D000818:Animals; D000951:Antigens, Neoplasm; D002460:Cell Line; D004250:DNA Topoisomerases, Type II / Q000235:genetics*; D004268:DNA-Binding Proteins; D005047:Etoposide / Q000494:pharmacology; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007527:Isoenzymes / Q000235:genetics*; D008156:Luciferases / Q000235:genetics; D051379:Mice; D008807:Mice, Inbred BALB C; D011401:Promoter Regions, Genetic; D012333:RNA, Messenger / Q000235:genetics; D014158:Transcription, Genetic; D014162:Transfection; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*
D000951:Antigens, Neoplasm; D004268:DNA-Binding Proteins; D007527:Isoenzymes; D012333:RNA, Messenger; D016159:Tumor Suppressor Protein p53; D005047:Etoposide; D008156:Luciferases; D004250:DNA Topoisomerases, Type II